Given their solid underlying businesses, reliable cash flows, high yields, and healthy growth prospects, these two high-yield Canadian stocks are ideal for your TFSA.
Real Brokerage (NASDAQ:REAX) Founder and CEO Tamir Poleg said the company had grown to more than 36,000 agents across the U.S. and Canada, positioning its technology-driven brokerage model for further expansion as it pursues its acquisition of RE/MAX Holdings.
Speaking at an Oppenheimer event, Pole
Tesla's record quarter looks impressive at first glance, but the numbers beneath it raise a much bigger question about the stock's future. Here's what investors need to know.
Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the wound-care company cited growth across its product portfolio and in U.S. and international markets.
Presid
For many Americans, working a few extra years before retiring seems like an easy solution if their savings aren’t where they want them to be. Personal finance expert Suze Orman says, “I’ll work longer” can be a smart
Rose Nicole Dominique Reich Sapire exercised stock options and withheld shares to cover tax obligations, retaining 15,246 direct shares and 65,520 options, per her latest Form 4.
AI hardware is becoming harder to manufacture, creating a critical opportunity few investors understand. See which companies could capture the upside and which risks could disrupt the thesis.
Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference.
Vance, who has been CEO for about 10 months after previously serving
